Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected SLC25A13 allele.
Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected SLC25A13 allele.
复制标题
肝内胆汁淤积婴儿柑橘缺乏症的分子诊断:鉴定出 21.7kb 的总缺失,该缺失完全沉默了受影响的 SLC25A13 等位基因的转录和翻译表达
DOI:
10.18632/oncotarget.19901
复制
发表时间:
2017-10-20
期刊:
影响因子:
--
通讯作者:
Song YZ
中科院分区:
文献类型:
--
作者:
Zhang ZH;Lin WX;Zheng QQ;Guo L;Song YZ
Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency (NICCD) arises from biallelic SLC25A13 mutations, and SLC25A13 analysis provides reliable evidences for NICCD definite diagnosis. However, novel large insertions/deletions in this gene could not be detected just by conventional DNA analysis. This study aimed to explore definite diagnostic evidences for an infant highly-suspected to have NICCD. Prevalent mutation screening and Sanger sequencing of SLC25A13 gene just revealed a paternally-inherited mutation c.851_854del4. Nevertheless, neither citrin protein nor SLC25A13 transcripts of maternal origin could be detected on Western blotting and cDNA cloning analysis, respectively. On this basis, the hidden maternal mutation was precisely positioned using SNP analysis and semi-quantitative PCR, and finally identified as a novel large deletion c.-3251_c.15+18443del21709bp, which involved the SLC25A13 promoter region and the entire exon 1 where locates the translation initiation codon. Hence, NICCD was definitely diagnosed in the infant. To the best of our knowledge, the novel gross deletion, which silenced the transcriptional and translational expression of the affected SLC25A13 allele, is the hitherto largest deletion in SLC25A13 mutation spectrum. The Western blotting approach using mitochondrial protein extracted from expanded peripheral blood lymphocytes, of particular note, might be a new minimally-invasive and more-feasible molecular tool for NICCD diagnosis.
登录
查看更多内容
影响因子:
4.6
作者:
Lin WX;Zeng HS;Zhang ZH;Mao M;Zheng QQ;Zhao ST;Cheng Y;Chen FP;Wen WR;Song YZ
通讯作者:
Song YZ
影响因子:
3.7
作者:
Autissier, Patrick;Soulas, Caroline;Williams, Kenneth C.
通讯作者:
Williams, Kenneth C.
影响因子:
8
作者:
Dimmock, David;Kobayashi, Keiko;Scaglia, Fernando
通讯作者:
Scaglia, Fernando
影响因子:
4.2
作者:
Hutchin, T.;Preece, M. A.;Baumann, U.
通讯作者:
Baumann, U.
DOI:
10.1016/j.bbamcr.2016.04.011
发表时间:
2016-10-01
影响因子:
5.1
作者:
Amoedo, N. D.;Punzi, G.;Rossignol, R.
通讯作者:
Rossignol, R.